Pesticide disrupts neuronal potentiation
The pesticide deltamethrin is widely considered a safer alternative to other chemicals, such as organophosphates due to being less toxic to mammals. However, previous studies in mice showed that deltamethrin exposure at early stages of development can lead to neuronal toxicity, but scientists do not understand the mechanism involved. Therefore, Leandra Koff and a team led by Fernanda Laezza from the Sealy Center of Environmental Health & Medicine at the University of Texas Medical Branch and colleagues in the U.S. investigated how deltamethrin induces neuronal toxicity and published their results in Molecular & Cellular Proteomics.
The team focused on brain-derived extracellular vesicles, or BDEVs, structures that transport molecules, such as signaling proteins, between cells in the brain. Because changes in the BDEV proteome can be a sign of disease, the team used a mass spectrometry–based approach to compare the protein content of BDEVs in mice exposed to deltamethrin and controls. They found several differentially expressed proteins between the two groups. Some alterations are associated with neuronal structure, transport and long-term potentiation, which promotes synaptic connections and plays a role in learning and memory. These proteomic differences could be one explanation for neuronal toxicity due to impaired nutrient transport and growth.
BDEV protein levels could be used as biomarkers to evaluate the risk of neurodevelopmental disorders. More research is needed to understand how these proteins disrupt neuronal function at later stages of development.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Life in four dimensions: When biology outpaces the brain
Nobel laureate Eric Betzig will discuss his research on information transfer in biology from proteins to organisms at the 2026 ASBMB Annual Meeting.

Fasting, fat and the molecular switches that keep us alive
Nutritional biochemist and JLR AE Sander Kersten has spent decades uncovering how the body adapts to fasting. His discoveries on lipid metabolism and gene regulation reveal how our ancient survival mechanisms may hold keys to modern metabolic health.

Redefining excellence to drive equity and innovation
Donita Brady will receive the ASBMB Ruth Kirschstein Award for Maximizing Access in Science at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

Mining microbes for rare earth solutions
Joseph Cotruvo, Jr., will receive the ASBMB Mildred Cohn Young Investigator Award at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

Fueling healthier aging, connecting metabolism stress and time
Biochemist Melanie McReynolds investigates how metabolism and stress shape the aging process. Her research on NAD+, a molecule central to cellular energy, reveals how maintaining its balance could promote healthier, longer lives.

Mapping proteins, one side chain at a time
Roland Dunbrack Jr. will receive the ASBMB DeLano Award for Computational Biosciences at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.